IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 28
Titolo Data di pubblicazione Autore(i) File
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 1-gen-2012 Franchina, Tindara; Amodeo, V; Proto, Claudia; Bronte, G; Savio, G; Russo, Alessandro; Toscano, G; Russo, A; Adamo, Vincenzo
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 1-gen-2013 Franchina, Tindara; Russo, Alessandro; Proto, C; Chiofalo, G; Picciotto, Maria; Scimone, A; Toscano, G; Berenato, R; Noto, L; Adamo, Vincenzo
Treatment option for small cell lung cancer: does lanreotide represent a new choice? 1-gen-2013 Franchina, Tindara; Proto, C; Russo, Alessandro; Chiofalo, G; Scimone, A; Adamo, Vincenzo
NSCLC and HER2: between lights and shadows 1-gen-2014 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Zanghì, Mariangela; Picone, Antonio; Scimone, Antonino; Adamo, Vincenzo
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 1-gen-2015 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 1-gen-2016 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer 1-gen-2016 Ricciardi, Giuseppina Rosaria Rita; Franchina, Tindara; Russo, Alessandro; Schifano, Silvia; Ferraro, Giuseppa; Adamo, Vincenzo
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site 1-gen-2016 Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria; Liguori, Giuseppina; Herberg, Astrid; Normanno, Nicola; Adamo, Vincenzo
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 1-gen-2016 Bronte, Giuseppe; Franchina, Tindara; Alù, Massimiliano; Sortino, Giovanni; Celesia, Claudia; Passiglia, Francesco; Savio, Giuseppina; Laudani, Agata; Russo, Alessandro; Picone, Antonio; Rizzo, Sergio; De Tursi, Michele; Gambale, Elisabetta; Bazan, Viviana; Natoli, Clara; Blasi, Livio; Adamo, Vincenzo; Russo, Antonio
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. 1-gen-2017 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 1-gen-2017 Russo, Alessandro; Franchina, T.; Ricciardi, G. R. R.; Smiroldo, V.; Picciotto, M.; Zanghì, M.; Rolfo, C.; Adamo, V.
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer 1-gen-2017 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Fanizza, Caterina; Scimone, Antonino; Chiofalo, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation 1-gen-2017 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Adamo, Vincenzo
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 1-gen-2017 Picciotto, Maria; Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria Rita; Provazza, Giusy; Sava, Serena; Baldari, Sergio; Caffo, Orazio; Adamo, Vincenzo
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review 1-gen-2018 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Toscano, G.; Schifano, S.; Lo Certo, G.; Battaglia, A.; Panto', E.; Scaffidi Fonti, M.; Adamo, V.
Acquired resistance in oncogene-addicted non-small-cell lung cancer 1-gen-2018 Sini, C.; Tuzi, A.; Rossi, G.; Russo, A.; Pezzuto, A.
Immunotherapy use in patients with HIV and non-small-cell lung cancer: Current data 1-gen-2019 Rolfo, Christian; Scilla, Katherinea; Russo, Alessandro
Mostrati risultati da 1 a 20 di 28
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile